Related Experiment Video

Updated: Jun 14, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis

Chia-Hsin Chan1, Szu-Wei Lee1,2, Chien-Feng Li3

  • 1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Nature Cell Biology
|April 13, 2010
PubMed

Insights

The Myc-Skp2-Miz1-p300 complex drives RhoA transcription, impacting cell migration and breast cancer metastasis. This reveals a new role for Skp2 beyond its E3 ligase function in cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Transcriptional Regulation

Background:

  • RhoA GTPase plays a critical role in cellular functions and is implicated in cancer metastasis.
  • The molecular mechanisms governing RhoA gene transcription remain poorly understood.

Purpose of the Study:

  • To elucidate the transcriptional regulation of RhoA.
  • To investigate the role of the Myc-Skp2-Miz1-p300 complex in RhoA transcription and cancer metastasis.

Main Methods:

  • Analysis of the Myc-Skp2-Miz1-p300 complex's interaction with the RhoA promoter.
  • Assessment of RhoA expression, cell migration, invasion, and metastasis in deficient complex models.
  • Correlation analysis of Myc-Skp2-Miz1 complex overexpression with RhoA expression in human cancers.

Main Results:

  • The Myc-Skp2-Miz1-p300 complex directly orchestrates RhoA transcription.
  • Skp2 collaborates with Myc to recruit Miz1 and p300 to the RhoA promoter, independent of SCF-Skp2 E3 ligase activity.
  • Deficiency of this complex impairs RhoA expression, cell migration, invasion, and breast cancer metastasis.
  • Overexpression of the Myc-Skp2-Miz1 complex is observed in metastatic cancers and correlates with RhoA levels.

Conclusions:

  • The Myc-Skp2-Miz1-p300 complex is a key regulator of RhoA transcription.
  • Oncogenic Skp2 and Myc coordinate to induce RhoA transcription through an SCF-Skp2 E3-ligase-independent mechanism.
  • This pathway represents a novel target for understanding and potentially treating cancer metastasis.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...